Open Offer23 Jun 2026, 08:47 am
Parmax Pharma: Open Offer for 26% Stake at ₹42.80 Per Share
AI Summary
Fedex Securities Pvt Ltd, acting as Manager to the Offer, has submitted a Draft Letter of Offer to BSE for the public shareholders of Parmax Pharma Ltd. This pertains to an open offer by Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with several persons acting in concert (PACs), to acquire up to 23,46,250 equity shares. This represents 26.00% of the expanded voting capital of Parmax Pharma. The offer price is fixed at ₹42.80 per equity share. The open offer is being made in compliance with SEBI (SAST) Regulations, 2011.
Key Highlights
- Open offer for 26% of Parmax Pharma's expanded voting capital.
- Offer price set at ₹42.80 per equity share.
- Acquirers include Dhiren Chandulal Shah and Sunil Chinubhai Shah.
- Draft Letter of Offer submitted to BSE by Manager to the Offer.
- Transaction is in compliance with SEBI (SAST) Regulations.
Price Impact
More from PARMAX